Tau proteins: New approach against Alzheimer’s in clinical trial
A novel drug to combat Alzheimer’s disease has shown good safety in a study involving more than 30 patients. The experimental…
Prof. Stefan Teipel talks about Alzheimer's and Lecanemab in health magazine "Apotheken Umschau"
The newly developed drug Lecanemab - this is the title story of the new issue of the German health…
Researchers at DZNE and the University Hospital Bonn, together with the Berlin-based company PeakProfiling GmbH, have developed a digital technology that recognizes the severity of speech…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
